Tag: Mark A. Swerdlow

Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer

David G. Armstrong, Mark A. Swerdlow, Alexandria A. Armstrong, Michael S. Conte, William V. Padula & Sicco A. Bus
Diabetic lower extremity complications remain enormously burdensome. Most notably, DFU and LEA appear to be more than just a marker of poor health. They are independent risk factors associated with premature death. While advances continue to improve outcomes of care for people with DFU and amputation, efforts should be directed at primary prevention as well as those for patients in diabetic foot ulcer remission to maximize ulcer-free, hospital-free and activity-rich days … read more


If you find WoundCareWeekly.com of value please consider a monthly donation to help cover expenses and keep this website going.